Search research articles
Contact Us
Filters
Showing results (451-460 of 571) with videos related to
Page
of 58
Sort By:
Clinical Kidney Journal
|
February 22, 2020
Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study
Raymond K Hsu, Chi-Yuan Hsu, Charles E McCulloch, et al.
JACC. Clinical Electrophysiology
|
September 19, 2024
Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm
Daniel E Singer, Steven J Atlas, Alan S Go, et al.
Circulation
|
December 6, 2012
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts
Jonathan P Piccini, Susanna R Stevens, YuChiao Chang, et al.
Journal of the American College of Cardiology
|
September 4, 2024
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
Renato D Lopes, Steven J Atlas, Alan S Go, et al.
Heart (British Cardiac Society)
|
June 8, 2018
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
Michael T Durheim, DaJuanicia N Holmes, Rosalia G Blanco, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 15, 2014
Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study
Kathleen D Liu, Wei Yang, Alan S Go, et al.
Circulation
|
September 11, 2013
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
Kidney International
|
July 25, 2020
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death
T Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb, et al.
Journal of the American Society of Nephrology : JASN
|
May 7, 2016
CKD Progression and Mortality among Hispanics and Non-Hispanics
Michael J Fischer, Jesse Y Hsu, Claudia M Lora, et al.
Page
of 58
Search research articles
Search
Showing results (451-460 of 571) with videos related to
Sort By:
Page
of 58
Clinical Kidney Journal
|
February 22, 2020
Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study
Raymond K Hsu, Chi-Yuan Hsu, Charles E McCulloch, et al.
JACC. Clinical Electrophysiology
|
September 19, 2024
Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm
Daniel E Singer, Steven J Atlas, Alan S Go, et al.
Circulation
|
December 6, 2012
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts
Jonathan P Piccini, Susanna R Stevens, YuChiao Chang, et al.
Journal of the American College of Cardiology
|
September 4, 2024
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
Renato D Lopes, Steven J Atlas, Alan S Go, et al.
Heart (British Cardiac Society)
|
June 8, 2018
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
Michael T Durheim, DaJuanicia N Holmes, Rosalia G Blanco, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
October 15, 2014
Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study
Kathleen D Liu, Wei Yang, Alan S Go, et al.
Circulation
|
September 11, 2013
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Jonathan P Piccini, Susanna R Stevens, Yuchiao Chang, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
Kidney International
|
July 25, 2020
A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death
T Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb, et al.
Journal of the American Society of Nephrology : JASN
|
May 7, 2016
CKD Progression and Mortality among Hispanics and Non-Hispanics
Michael J Fischer, Jesse Y Hsu, Claudia M Lora, et al.
Page
of 58